The Blood Grouping Reagents Market in China saw significant growth from 2013 to 2023, standing at 352.47 million USD in 2023. The highest annual growth rate of 50.8% occurred in 2015, while a notable dip of -6.22% happened in 2017. Over the past two years, the market grew by a steady 3.9% in 2023 and 4.15% in 2022. The last five-year CAGR was 3.83%, indicating a stable but moderate expansion.
Future trends to watch for include:
- Advancements in blood diagnostic technologies
- Increased healthcare expenditure in China
- Aging population requiring more medical care
- Government initiatives to improve healthcare infrastructure
- Potential impacts of global health situations on market dynamics
